Write to Baxter International’s CEO Brent Shafer today and demand action on a 25-year-old commitment Baxter has failed to fulfill.

In 1999, Baxter promised shareholders it would phase out toxic PVC and DEHP in its IV bags and tubing – chemicals linked to:

• Breast, liver, colorectal, and ovarian cancers

• Hormone disruption

• Birth defects

• Drug resistance and treatment interference

• Neurodevelopment

• Increased breast cancer relapse and mortality

• Dioxin pollution

While Baxter introduced some PVC- and DEHP-free alternatives early on, the company never fully followed through in phasing out PVC and DEHP IVs and continues to profit from outdated, dangerous products.

DEHP migrates from PVC IV bags directly into patients’ bodies, raising risks for everyone, especially vulnerable populations like newborns, pregnant individuals and cancer patients

PVC manufacturing and disposal release dioxins: carcinogens that pollute communities and increase breast cancer risk.
Meanwhile, California has banned DEHP in IVs, and other states are following suit. The market for safer, non-PVC IVs is growing fast.

Baxter is at a moral and strategic crossroads.

✅ Leading hospitals like CommonSpirit, Kaiser Permanente, City of Hope, Loma Linda University Health and Sharp Healthcare have committed to providing care with PVC- and DEHP-free IVs.
✅ Legislation is advancing across the U.S.
✅ Baxter can lead – or be left behind.

 Join our letter-writing campaign to tell Baxter: Patients and frontline healthcare workers deserve safer IVs. It’s time to finish what you started.